We just put up a blog post over at MyAFibExperience.org, a site co-developed by American Heart Association and StopAfib.org. The post shares some of the information on blood thinners and prevention of afib-related strokes that we gleaned from the recent 2016 Atrial Fibrillation Symposium in Orlando. We hope these nuggets are good food for thought …
Read More
The Catheter Ablation Panel at the 2015 Get in Rhythm, Stay in Rhythm National Atrial Fibrillation Patient Conference was chaired by Robert C. Kowal, MD, PhD, FHRS, and included: Andrea Natale, MD, FHRS; Nassir Marrouche, MD, FHRS; and Sanjiv M. Narayan, MD, PhD. The video of the panel contains two hours of introductory and advanced …
Read More
For World Stroke Day, the Sign Against Stroke (SAS) in Atrial Fibrillation Task Force launched patient empowerment materials for afib patients, family members, and healthcare providers. StopAfib.org is co-chair of the SAS Task Force and chaired development of these materials. Read more about these patient empowerment materials, which include infographic posters, downloadable PDFs, and videos, …
Read More
The Living with Afib session at the 2015 Get in Rhythm, Stay in Rhythm National Atrial Fibrillation Patient Conference was presented by StopAfib.org Founder and CEO, Mellanie True Hills, who spoke about: • dedicating the conference to Judy Currier • knowing your stroke risk • autoimmune diseases and afib • common issues such as alcohol, …
Read More
In his talk about Avoiding Afib Strokes at the 2015 Get in Rhythm, Stay in Rhythm National Atrial Fibrillation Patient Conference, Dr. Mintu Turakhia of Stanford University discussed how our thinking about afib and stroke, and when to treat, has changed over the last couple of years. Access Dr. Turakhia’s talk at: Video: Avoiding Afib …
Read More
Are you joining us on March 28-29 in Dallas to learn from our world-renowned afib experts on how to get in rhythm and stay in rhythm? Afib patients are coming from all over to be here, and we hope you can join us, too. Learn more about the conference, and register, at: Afib Patients from …
Read More
Big news! Boehringer Ingelheim has submitted an application to the FDA requesting accelerated approval for idarucizumab, the reversal agent for Pradaxa (dabigatran). See: Boehringer Ingelheim Submits Biologics License Application to FDA for Idarucizumab*, Investigational Specific Reversal Agent for Pradaxa® Additionally, they have submitted for marketing approval by Health Canada and the European Medicines Agency (EMA). See: Boehringer …
Read More
Plan to join us March 28-29, 2015, at the StopAfib.org National Atrial Fibrillation Patient Conference to hear our rock-star cast of afib experts share ways for you to get in rhythm and stay in rhythm. This is a not-to-be-missed event—take a look at who’s speaking! The conference will be held at the Hyatt Regency DFW …
Read More
Here's more good news about the upcoming antidote for Eliquis - see: Positive Results for Factor Xa Inhibitor Antidote: ANNEXA-A
Read More
Today, at the European Society of Cardiology Congress in Barcelona, it was reported that even though 80% of atrial fibrillation patients who should be on anticoagulants (according to their CHA2DS2-VASc score) are on anticoagulants, death rates at one year are still high. Most of those deaths are due to cardiovascular causes. The risk factors predicting …
Read More